BioNTech Reports Downbeat Earnings, Joins Medical Properties Trust And Other Big Stocks Moving Lower In Monday's Pre-Market Session

U.S. stock futures were higher this morning, with the Dow futures gaining over 100 points on Monday.

Shares of BioNTech SE BNTX fell sharply in today's pre-market trading following weaker-than-expected first-quarter earnings.

BioNTech posted quarterly GAAP loss of €1.31 per share, missing estimates of €0.97 per share. The company's sales came in at €187.600 million missing estimates of €427.500 million.

BioNTech shares fell 4.4% to $88.65 in pre-market trading in pre-market trading.

Here are some big stocks recording losses in today's pre-market trading session.

  • Medical Properties Trust, Inc MPW shares declined 14.4% to $4.17 in pre-market trading after tenant Steward Health Care reportedly filed for bankruptcy protection.
  • Embotelladora Andina S.A.  AKO fell 10.8% to $16.65 pre-market trading after gaining 4% on Friday.
  • Luminar Technologies, Inc. LAZR shares declined 9.5% to $1.52 in pre-market trading after the company announced a workforce reduction.
  • MMTec, Inc. MTC dipped 8% to $2.19 in pre-market trading after declining 4% on Friday.
  • Ocular Therapeutix, Inc. OCUL shares fell 7.6% to $5.70 in pre-market trading after gaining 5% on Friday.
  • ADC Therapeutics SA. ADCT shares declined 6.3% to $4.59 in pre-market trading after the company posted weak quarterly sales.
  • Victoria’s Secret & Co VSCO fell 5% to $16.67 pre-market trading. Morgan Stanley analyst Alexandra Steiger downgraded Victoria’s Secret from Equal-Weight to Underweight and lowered the price target from $19 to $15.

Now Read This: Jim Cramer Says ‘You’re In Good Hands’ With This ‘Very Good’ Regional Bank, Likes General Motors

Don't forget to check out our premarket coverage here

Market News and Data brought to you by Benzinga APIs
Posted In: NewsPre-Market OutlookMarketsMoversTrading IdeasLosersPremarket
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!